Read about the types of targeted therapies used for Hodgkin lymphoma, how you have them and possible side effects.
Brentuximab and rituximab are a type of monoclonal antibody (targeted drug). They target specific proteins on lymphoma cells and help the immune system to pick out these cells and kill them.
Find out what Brentuximab is, how you have it and other important information about taking this cancer drug.
Find out what rituximab is, how you have it for nodular lymphocyte predominant Hodgkin lymphoma, and other important information about taking the cancer drug.